epitope corresponding to amino acids 81-350 mapping within an N-terminal extracellular domain of Matriptase of human origin
Modification Notes
Matriptase (also known as MT-SP1, ST14, prostamin and epithin) is a tumor-associated type II transmembrane serine protease that is highly expressed in many human cancer-derived cell lines and is implicated in extracellular matrix re-modeling, tumor growth, and metastasis (1-7). Matriptase performs pleiotropic functions in the development of the epidermis, hair follicles, and cellular immune system (3). Sphingosine 1-phosphate (S1P, SPP), present in serum-derived lipoproteins, activates matriptase (5) while matriptase activates both urokinase-type plasminogen activator and hepatocyte growth factor (HGF) (6). Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is a Kunitz-type serine protease inhibitor identified as a strong inhibitor of matriptase and HGF (7). Advanced-stage ovarian tumors that express matriptase are more likely to do so in the absence of its inhibitor, HAI-1, indicating that an imbalance in the matriptase:HAI-1 ratio could be important in the development of advanced disease (2).
Key Feature
Clonality
Polyclonal
Isotype
IgG
Host Species
Rabbit
Tested Applications
WBIPIFELISA
recommended for detection of Matriptase of mouse, rat and human origin by WB, IP, IF and ELISA:
Species Reactivity
HumanMouseRat
Concentration
1mg/ml
Purification
Affinity purified
Target Information
Alternative Names
epitope corresponding to amino acids 81-350 mapping within an N-terminal extracellular domain of Matriptase of human origin
Tissue Specificity
epitope corresponding to amino acids 81-350 mapping within an N-terminal extracellular domain of Matriptase of human origin